Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Beta-d-glucose
Drug ID BADD_D00257
Description A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
Indications and Usage Not Available
Marketing Status experimental
ATC Code V06DC01; V04CA02; B05CX01
DrugBank ID DB02379
KEGG ID D02325; D00009
MeSH ID D005947
PubChem ID 64689
TTD Drug ID D07ONX
NDC Product Code Not Available
UNII J4R00M814D
Synonyms Glucose | D-Glucose | D Glucose | Dextrose | Glucose, (alpha-D)-Isomer | Anhydrous Dextrose | Dextrose, Anhydrous | Glucose, (DL)-Isomer | Glucose, (L)-Isomer | L-Glucose | L Glucose | Glucose Monohydrate | Monohydrate, Glucose | Glucose, (beta-D)-Isomer
Chemical Information
Molecular Formula C6H12O6
CAS Registry Number 492-61-5
SMILES C(C1C(C(C(C(O1)O)O)O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abscess11.01.08.001---
Acidosis14.01.03.002--
Agitation17.02.05.012; 19.06.02.001--
Asthenia08.01.01.001---
Body temperature increased13.15.01.001---
Cardiac failure congestive02.05.01.002---
Coma17.02.09.001---
Confusional state17.02.03.005; 19.13.01.001--
Dehydration14.05.05.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Extravasation08.01.03.008---
Feeling abnormal08.01.09.014---
Fluid retention14.05.06.002; 20.01.02.003---
Haemolysis01.06.04.002--
Headache17.14.01.001--
Hypernatraemia14.05.04.001--
Hypertension24.08.02.001--
Hypervolaemia02.05.04.019; 14.05.06.003---
Hypokalaemia14.05.03.002--
Irritability08.01.03.011; 19.04.02.013--
Lacrimation increased06.08.02.004--
Loss of consciousness17.02.04.004---
Necrosis08.03.03.001; 24.04.02.006---
Nervous system disorder17.02.10.001---
Oedema08.01.07.006; 14.05.06.010---
Pain08.01.08.004--
Phlebitis12.02.01.002; 24.12.03.004--
Pulmonary embolism22.06.02.001; 24.01.06.001---
Respiratory failure14.01.04.003; 22.02.06.002--
Salivary hypersecretion07.06.01.009---
The 1th Page    1 2    Next   Last    Total 2 Pages